For our client, an international pharma company in Zürich, we are looking for an Associate Director, Global Payer Value & Access – Vaccines
In this role, you will be responsible for developing and executing global market access, pricing, and reimbursement strategies to optimize the value of a product across key markets.
...
This role plays a pivotal function in ensuring the product achieves broad and sustainable access by aligning pricing models, payer value propositions, and evidence-generation strategies with public health priorities and payer expectations.
General Information:
- Start date: ASAP
- End date: 31/03/2026
- Extension: to be clarified
- Workplace: canton Zürich/remote
- Workload: 100%
- Home office: flexible, role can be remote (within Switzerland)
- Travel: limited required
Tasks and Responsibilities:
1. Global Pricing & Market Access Strategy:
- Refine global pricing, reimbursement, and access strategies that balance affordability, value, and sustainability across diverse markets.
- Define payer segmentation and engagement frameworks, considering procurement structures such as PAHO Revolving Fund, GAVI, UNICEF, national tendering systems, and private markets.
- Support with global pricing scenario analysis, accounting for factors such as competitor entry (e.g., pipeline vaccines, alternative technologies or shifting procurement trends), tendering strategies, and volume-based contracting.
- Support regional teams in negotiation strategy development, ensuring alignment with local payer dynamics.
2. Life Cycle Management & Competitive Positioning:
- Support in refining life cycle pricing strategies, considering items such as multi-dose vial introduction, new evidence, policy shifts (e.g. new WHO recommendation) etc.
- Monitor global market trends, competitor dynamics, and policy shifts that impact vaccine access (e.g., WHO guidance, HTA policy changes, and pandemic preparedness initiatives).
- Support regional teams in adapting access strategies in response to new market entrants, evolving public procurement mechanisms, and changes in government funding.
3. Region and LOC support in Execution of Access and Pricing Strategies:
- Act as a global point of contact for regional and local market access teams, ensuring consistent execution of pricing and access strategies while adapting to local payer dynamics.
- Support LOCs in defining, refining, and executing market access and pricing strategies, ensuring alignment with global guidance and best practices.
- Provide strategic guidance on tender participation, volume-based agreements, and innovative contracting models to optimize market access outcomes.
- Assist in the development and localization of Global Value Dossiers (GVDs), health economic models, and pricing frameworks to strengthen reimbursement submissions and payer negotiations.
- Support NITAG engagements, including proactive and reactive responses, ensuring strong advocacy for vaccine inclusion in National Immunization Programs (NIPs).
- Facilitate regional knowledge-sharing and capability-building initiatives, strengthening the payer engagement skills of local teams and enhancing execution excellence.
- Support preparation and delivery of local advisory boards (ad-boards) to gather payer and policymaker insights, refining value communication strategies accordingly.
4. Data & Digital-Driven Access Perspective:
- Leverage digital platforms and value communication tools (e.g., Dengue.com) to enhance payer engagement, ensuring seamless access to evidence-based insights that support the product's value messaging.
- Utilize AI-driven pricing analytics, real-world data (RWD), and forecasting models to optimize access strategies and anticipate shifts in procurement and reimbursement trends.
5. Ad hoc support:
5.1. Payer Value Proposition Development & Execution:
- Refine Global Value Dossiers (GVDs), payer negotiation toolkits, and objection-handling materials and other key tools to support local market access and pricing teams.
- Ensure alignment of clinical, economic, and public health value messaging with payer needs and policy priorities.
- Collaborate with public affairs and policy teams to support funding advocacy, vaccine inclusion in national programs (NIPs), and health system strengthening initiatives.
5.2. Evidence Generation & HEOR Integration:
- Partner with HEOR teams to design and execute cost-effectiveness models, budget impact analyses, and real-world evidence (RWE) strategies that reinforce vaccine value.
- Proactively shape post-launch RWE initiatives to ensure long-term pricing sustainability and policy support.
Your Profile:
- Advanced degree in health economics, public health, business, pharmacy, or related field (MBA, MSc, MPH, PharmD preferred).
- 5+ years of experience in Market Access, Pricing, HEOR, or Public Affairs, with a strong focus on vaccines.
- Deep understanding of global vaccine reimbursement frameworks, public procurement dynamics, and multi-lateral funding mechanisms (e.g., GAVI, PAHO, UNICEF, national HTA agencies, and NIPs).
- Proven ability to engage with payers, policymakers, and health system stakeholders to shape vaccine access policies.
- Experience working in emerging markets, with direct exposure to vaccine pricing and reimbursement negotiations.
- Excellent communication skills and ability to influence cross-functional teams across global, regional, and country levels.
Nice to have:
- Experience with PDP agreements, tech transfer pricing models, and innovative access strategies.
- Background in volume-based agreements, tiered pricing, and alternative financing mechanisms for vaccines.
- Familiarity with health system financing and procurement models in LMICs.
